Evidence map›Paper›PMID 39394456›Full record

ArticleMolecular psychiatry2025

Gaze behaviors during free viewing revealed differences in visual salience processing across four major psychiatric disorders: a mega-analysis study of 1012 individuals.

Kenichiro Miura, Masatoshi Yoshida, Kentaro Morita, Michiko Fujimoto, Yuka Yasuda, Hidenaga Yamamori, Junichi Takahashi, Seiko Miyata, Kosuke Okazaki, Junya Matsumoto and 7 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kenichiro MiuraDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, 184-8553, Japan. miura.kenichiro.2x@ncnp.go.jp.
Masatoshi YoshidaCenter for Human Nature, Artificial Intelligence, and Neuroscience (CHAIN), Hokkaido University, Sapporo, 060-0812, Japan. myoshi@chain.hokudai.ac.jp.
Kentaro MoritaDepartment of Rehabilitation, University of Tokyo Hospital, Tokyo, 113-8655, Japan.
Michiko FujimotoDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, 184-8553, Japan.
Yuka YasudaDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, 184-8553, Japan.
Hidenaga YamamoriDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, 184-8553, Japan.
Junichi TakahashiDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, 812-8582, Japan.
Seiko MiyataDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Kosuke OkazakiDepartment of Psychiatry, Nara Medical University School of Medicine, Kashihara, 634-8521, Japan.
Junya MatsumotoDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, 184-8553, Japan.ORCID 0000-0003-4228-3208
Atsuto ToyomakiDepartment of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, 060-8638, Japan.
Manabu MakinodanDepartment of Psychiatry, Nara Medical University School of Medicine, Kashihara, 634-8521, Japan.ORCID 0000-0003-4339-9413
Naoki HashimotoDepartment of Psychiatry, Hokkaido University Graduate School of Medicine, Sapporo, 060-8638, Japan.
Toshiaki OnitsukaNHO Sakakibara Hospital, Tsu, 514-1292, Japan.
Kiyoto KasaiDepartment of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.ORCID 0000-0002-4443-4535
Norio OzakiPathophysiology of Mental Disorders, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
Ryota HashimotoDepartment of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, 184-8553, Japan.ORCID 0000-0002-5941-4238

Funding

Japan Agency for Medical Research and Development (AMED) JP18dm0307002Japan Agency for Medical Research and Development (AMED) JP19dm0207069Japan Agency for Medical Research and Development (AMED) JP21dk0307103Japan Agency for Medical Research and Development (AMED) JP21uk1024002Japan Agency for Medical Research and Development (AMED) JP21wm0425012Japan Agency for Medical Research and Development (AMED) JP23ak0101215MEXT | Japan Society for the Promotion of Science (JSPS) 20K06920MEXT | Japan Society for the Promotion of Science (JSPS) 22H02936MEXT | Japan Society for the Promotion of Science (JSPS) JP20K06920MEXT | Japan Society for the Promotion of Science (JSPS) JP23K07001
6 · The paper itself

Abstract

Aberrant salience processing has been proposed as a pathophysiological mechanism underlying psychiatric symptoms in patients with schizophrenia. The gaze trajectories of individuals with schizophrenia have been reported to be abnormal when viewing an image, suggesting anomalous visual salience as one possible pathophysiological mechanism associated with psychiatric diseases. This study was designed to determine whether visual salience is affected in individuals with schizophrenia, and whether this abnormality is unique to patients with schizophrenia. We examined the gaze behaviors of 1012 participants recruited from seven institutes (550 healthy individuals and 238, 41, 50 and 133 individuals with schizophrenia, bipolar disorder, major depressive disorder and autism spectrum disorder, respectively) when they looked at stationary images as they liked, i.e., free-viewing condition. We used an established computational model of salience maps derived from low-level visual features to measure the degree to which the gaze trajectories of individuals were guided by visual salience. The analysis revealed that the saliency at the gaze of individuals with schizophrenia were higher than healthy individuals, suggesting that patients' gazes were guided more by low-level image salience. Among the low-level image features, orientation salience was most affected. Furthermore, a general linear model analysis of the data for the four psychiatric disorders revealed a significant effect of disease. This abnormal salience processing depended on the disease and was strongest in patients with schizophrenia, followed by patients with bipolar disorder, major depressive disorder, and autism spectrum disorder, suggesting a link between abnormalities in salience processing and strength/frequency for psychosis of these disorders.

Indexed as

Fixation, OcularVisual PerceptionAdultAutism Spectrum DisorderBipolar DisorderEye MovementsFemaleHumansMajor Depressive DisorderMaleMental DisordersMiddle AgedPhotic StimulationSchizophrenia

Identifiers

PMID39394456
PMCPMC11919774

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.